Idiopathic hyperCKemia and malignant hyperthermia susceptibility-Reference-Cited by-同舟云学术

Idiopathic hyperCKemia and malignant hyperthermia susceptibility

Published:2017-09-26 Issue:12 Volume:64 Page:1202-1210
ISSN:0832-610X
Container-title:Canadian Journal of Anesthesia/Journal canadien d'anesthésie
language:en
Short-container-title:Can J Anesth/J Can Anesth

Author:

Santos Joilson M.,Andrade Pamela V.,Galleni Leonardo,Vainzof Mariz,Sobreira Claudia F. R.,Schmidt Beny,Oliveira Acary S. B.,Amaral José L. G.,Silva Helga C. A.

Funder

Fundação de Auxílio à Pesquisa do Estado de São Paulo

Fundação de Auxílio à Pesquisa do Estado de São Paulo – Centro de Pesquisa, Inovação e Difusão

Conselho Nacional de Desenvolvimento Científico e Tecnológico - Instituto Nacional de Ciência e Tecnologia

Publisher

Springer Science and Business Media LLC

Subject

Anesthesiology and Pain Medicine,General Medicine

Link

http://link.springer.com/article/10.1007/s12630-017-0978-x/fulltext.html

Reference39 articles.

1. Roman BB, Wieringa B, Koretsky AP. Functional equivalence of creatine kinase isoforms in mouse skeletal muscle. J Biol Chem 1997; 272: 17790-4.

2. Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJ, deVisser M. Rhabdomyolysis: review of the literature. Neuromuscul Disord 2014; 24: 651-9.

3. Kyriakides T, Angelini C, Schaefer J, European Federation of Neurological Societies, et al. EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur J Neurol 2010; 17: 767-73.

4. Prelle A, Tancredi L, Sciacco M, et al. Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels. J Neurol 2002; 249: 305-11.

5. Weglinski MR, Wedel DJ, Engel AG. Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels. Anesth Analg 1997; 84: 1038-41.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Familial hyperCKemia with exercise-induced myalgia associated with a novel missense variant in RYR1;Brain and Development Case Reports;2024-09

2. Epidemiological and clinical features of malignant hyperthermia: A scoping review;Clinical Genetics;2023-12-26

3. Evaluation of Malignant Hyperthermia Features in Patients with Pathogenic or Likely Pathogenic RYR1 Variants Disclosed through a Population Genomic Screening Program;Anesthesiology;2023-10-03

4. Patient suspected susceptibility to malignant hyperthermia: impact of the disease;Brazilian Journal of Anesthesiology (English Edition);2023-03

5. Neuromuscular symptoms in patients with RYR1-related malignant hyperthermia and rhabdomyolysis;Brain Communications;2022-11-02